Literature DB >> 14663108

Coagulase-negative staphylococci: clinical, microbiological and molecular features to predict true bacteraemia.

Patricia García1, Rosana Benítez1, Marusella Lam1, Ana María Salinas1, Hans Wirth1, Claudia Espinoza1, Tamara Garay1, María Soledad Depix1, Jaime Labarca1, Ana María Guzmán1.   

Abstract

Coagulase-negative staphylococci (CNS) are frequently isolated from blood cultures, where they may be only a contaminant or the cause of bacteraemia. Determining whether an isolate of CNS represents a true CNS bacteraemia is difficult, and there is no single criterion with sufficient specificity. The aim of this study was to assess those clinical, microbiological, pathogenic and genotypic features that characterize true CNS bacteraemia. Twenty patients having two or more blood cultures positive for CNS and 20 patients with only one positive blood culture were studied. Significant bacteraemia was defined according to clinical and laboratory criteria. Incubation time for blood cultures to become positive, macroscopic appearance of colonies, species determination, biotype, susceptibility to antimicrobials, PFGE pattern and adherence capacity were all studied. Clinical bacteraemia was present in 16/20 patients with two or more positive blood cultures and in 2/20 patients with only one positive blood culture. A significant difference was seen in the median time to positivity between the 18 clinical bacteraemias and 22 contaminations (23.6 versus 29.2 h; P = 0.04, Wilcoxon). There was also a significant difference between the two groups in the median absorbance of the slime test (1.36 versus 0.58; P = 0.005). All significant bacteraemias with two or more positive blood cultures had the same species identified, the same antimicrobial susceptibility pattern and the same PFGE pattern. In two patients with true bacteraemia with only one positive blood culture, the incubation time for the culture to turn positive was <24 h and the slime production absorbance was >2.5. The most useful parameters for the diagnosis of true CNS bacteraemia for patients with two positive blood cultures were incubation time until positive, species identification, antimicrobial susceptibility pattern, slime production and PFGE pattern. For patients with only one blood culture positive for CNS, the useful parameters for prediction of true bacteraemia were incubation time until positive and slime production, both of which are simple, low-cost tests.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14663108     DOI: 10.1099/jmm.0.04994-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

1.  Comparative study using phenotypic, genotypic, and proteomics methods for identification of coagulase-negative staphylococci.

Authors:  Anne J M Loonen; Arjan R Jansz; Jeandery N B Bergland; Marion Valkenburg; Petra F G Wolffs; Adriaan J C van den Brule
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Strong slime production is a marker of clinical significance in Staphylococcus epidermidis isolated from intravascular catheters.

Authors:  M Mateo; J R Maestre; L Aguilar; M J Giménez; J J Granizo; J Prieto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12-18       Impact factor: 3.267

3.  Evaluation of quantitative antibiotic susceptibility testing by Vitek 2 as a routine method to predict strain relatedness of coagulase-negative staphylococci isolated from blood cultures.

Authors:  Antonia Camerer; Anke Kohlenberg; Danuta Stefanik; Harald Seifert
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

4.  Comparison of coagulase-negative staphylococci isolated from blood cultures as a true bacteremia agent and contaminant in terms of slime production and methicillin resistance.

Authors:  Muhammet Hamidullah Uyanik; Halil Yazgi; Kemalettin Ozden; Zeynep Erdil; Ahmet Ayyildiz
Journal:  Eurasian J Med       Date:  2014-06

Review 5.  A 'culture' shift: Application of molecular techniques for diagnosing polymicrobial infections.

Authors:  Yi Zhang; Anne Hu; Nadya Andini; Samuel Yang
Journal:  Biotechnol Adv       Date:  2019-02-20       Impact factor: 14.227

6.  Clonal diversity in episodes with multiple coagulase-negative Staphylococcus bloodstream isolates suggesting frequent contamination.

Authors:  U Seybold; C Reichardt; J S Halvosa; H M Blumberg
Journal:  Infection       Date:  2008-10-30       Impact factor: 3.553

7.  Detection of Bacteria Bearing Resistant Biofilm Forms, by Using the Universal and Specific PCR is Still Unhelpful in the Diagnosis of Periprosthetic Joint Infections.

Authors:  Batool H Zegaer; Anastasios Ioannidis; George C Babis; Vassiliki Ioannidou; Athanassios Kossyvakis; Sotiris Bersimis; Joseph Papaparaskevas; Efthimia Petinaki; Paraskevi Pliatsika; Stylianos Chatzipanagiotou
Journal:  Front Med (Lausanne)       Date:  2014-09-16

8.  Universal digital high-resolution melt: a novel approach to broad-based profiling of heterogeneous biological samples.

Authors:  Stephanie I Fraley; Justin Hardick; Billie J Masek; Billie Jo Masek; Pornpat Athamanolap; Richard E Rothman; Charlotte A Gaydos; Karen C Carroll; Teresa Wakefield; Tza-Huei Wang; Samuel Yang
Journal:  Nucleic Acids Res       Date:  2013-08-09       Impact factor: 16.971

9.  Utility of sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patients.

Authors:  Franz Ratzinger; Michael Schuardt; Katherina Eichbichler; Irene Tsirkinidou; Marlene Bauer; Helmuth Haslacher; Dieter Mitteregger; Michael Binder; Heinz Burgmann
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

10.  SeptiFast for diagnosis of sepsis in severely ill patients from a Brazilian hospital.

Authors:  Roberta Sitnik; Alexandre Rodrigues Marra; Roberta Cardoso Petroni; Ozires Pereira Santos Ramos; Marinês Dalla Valle Martino; Jacyr Pasternak; Oscar Fernando Pavão dos Santos; Cristóvão Luis Pitangueira Mangueira; João Renato Rebello Pinho
Journal:  Einstein (Sao Paulo)       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.